Biomarker Tissue Journey Among Patients With Untreated Metastatic Non–Small Cell Lung Cancer in the U.S. Oncology Network Community Practices
Last Updated: Friday, July 23, 2021
This real-world study showed that while most patients had at least one biomarker test result available prior to first-line therapy, less than 50 % had five or more biomarkers tested. The median time from diagnosis to first-line therapy was about 5 weeks. Most of the population was diagnosed at advanced disease, with roughly over 80% detected at stage 4.
Advertisement
News & Literature Highlights
